In conclusion, ATL-PI is a PI for patients with aggressive ATL, anditisapplicableforbothacuteandlymphomatypesseparately.We believeATL-PIisapromisingtoolforriskstratification.Wehopethat it will be validated internationally in studies that include patients treated with a combination of interferon alfa